The microbiota-gut-brain axis and neurodevelopmental disorders.

Wang Q, Wang Q, Yang Q, Liu X. · 2023

Read The microbiota-gut-brain axis and neurodevelopmental disorders. by Wang Q, Wang Q, Yang Q, Liu X. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc10599644.txt.

Introduction

Wang, Wang, Yang, and Liu reviewed in 2023 how gut microbes may shape brain growth in children. Microbes in the gut talk to the brain through a two-way route, the microbiota-gut-brain axis. That talk steers body processes as the brain forms. Faults in the talk may feed disorders of brain growth.

Three paths carry the signals, Wang reports: immune, nerve, and hormone routes. The paths overlap and cross-talk as they run. Studies now link the axis to autism, ADHD, and Rett syndrome, a rare growth disorder. The review sums up what each link rests on. It also flags where proof is thin and what tests come next.

Catalog record

CREATORWang Q, Wang Q, Yang Q, Liu X.
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE86 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10599644

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The microbiota–gut–brain axis and neurodevelopmental disorders By Qinwen Wang, Qianyue Yang, Xingyin Liu Published in: Protein & Cell DOI: 10.1093/procel/pwad026 ABSTRACT Abstract The gut microbiota has been found to interact with the brain through the microbiota–gut–brain axis, regulating various physiological processes. In recent years, the impacts of the gut microbiota on neurodevelopment through this axis have been increasingly appreciated. The gut microbiota is commonly considered to regulate neurodevelopment through three pathways, the immune pathway, the neuronal pathway, and the endocrine/systemic pathway, with overlaps and crosstalks in between. Accumulating studies have identified the role of the microbiota–gut–brain axis in neurodevelopmental disorders including autism spectrum disorder, attention deficit hyperactivity disorder, and Rett Syndrome. Numerous researchers have examined the physiological and pathophysiological mechanisms influenced by the gut microbiota in neurodevelopmental disorders (NDDs). This review aims to provide a comprehensive overview of advancements in research pertaining to the microbiota-gut-brain axis in NDDs. Furthermore, we analyzed both the current state of research progress and discuss future perspectives in this field. INTRODUCTION A staggering amount of research has found that the gut interacts with the brain in a bidirectional manner, known as the gut–brain axis. Inside the gut, the resident microorganism communities acting as a key regulator of the gut–brain axis have attracted even more attention. These communities include bacteria, fungi, viruses, and other forms of life, collectively known as the microbiome (Davenport et al., 2017). On the one hand, diverse physiological processes in the intestine, such as gastrointestinal (GI) motility, secretion, and digestive functions are modulated by the central nervous system (CNS) (Taché et al., 1980; Browning and Travagli, 2014). On the other hand, the gut microbiome influences brain function neurally, humorally, and immunologically (Dinan and Cryan, 2017; Maniscalco and Rinaman, 2018; Agustí et al., 2018). To be more specific, it is now widely accepted that this interaction is conducted through three major pathways, the immune pathway, the neuronal pathway, and the endocrine/systemic pathway, with interactions and crosstalks between these three (Agirman and Hsiao, 2021). According to the diagnostic and statistical manual of mental disorders (DSM-5) (American Psychiatric Association, 2013), NDDs are a group of conditions which manifest during the developmental period and typically occurs in early development. NDDs are generally characterized by deficits in terms of personal, social, academic, and occupational functions. Typical NDDs include autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), as well as certain types of learning and motor disabilities. As researchers look deeper into the overlapped area between microbiology and neuroscience, it is becoming more apparent that the gut microbiota has a strong correlation with NDDs (Table 1). Numerous researchers have examined the physiological and pathophysiological mechanisms influenced by the gut microbiota in NDDs. This review aims to provide a comprehensive overview of advancements in research pertaining to the microbiota-gut-brain axis in NDDs. Furthermore, we will analyze both the current state of research progress and future perspectives in this field to provide a more thorough understanding of the topic. [Table: Summary of gut microbiota changes in NDDs.] NDDS AND THE IMMUNE PATHWAY MEDIATED BY GUT MICROBIOME The CNS is vulnerable to various perturbations during development and altered immunological conditions may contribute to pathological processes in NDDs (Rodier, 1994; Han et al., 2021). Specifically, the gut microbiota interacts with the immune system by the residence itself, microbial-derived metabolites, such as short-chain fatty acids (SCFAs), secondary bile acids, and amino acid metabolites, and other bioactive molecules, such as microbe-associated molecular patterns (MAMPs) (Cryan et al., 2019). Together, they modulate local immunity within the gut, affecting the CNS through systemic circulation, and also play a modulating role with microglia as a mediator (Fig. 1). [Figure: The immune pathway. Along the immune pathway, the gut microbiota regulates the brain by the bacteria themselves, microbial-derived metabolites (e.g., SCFAs, secondary bile acids, and amino acid metabolites), bacterial cell wall components (e.g., peptidoglycan, LPS), as well as microbial-intrigued immune cells and their secretory factors. The gut microbiota modulates enteric immunity in terms of the intestinal barrier, peripheral immune cells, and cytokines. For example, SCFAs derived by the gut microbiota seem to maintain a symbiotic relationship with the host by suppressing immune responses and protecting commensal bacteria from elimination, while also enhancing enteric barriers and reduce gut permeability to prevent invasion by harmful microorganisms. Proofs are that SCFAs have restrictive effects on neutrophil chemotaxis and mononuclear phagocyte system, promoting effect on regulatory T cells (Treg cells) and SCFAs can alleviate gut epithelium injury and regulate tight junctions. Meanwhile, in the CNS, microglia act as an important agent in neurodevelopment through their functions of synaptic pruning, neural progenitor cells (NPCs) pool supervision, neurogenesis regulation, etc. The gut microbiota affects microglia from different ways, exerting considerable effects on the neurodevelopmental process.] Gut microbiota act as important regulators of the enteric immunity locally. Bacteria, along with bacterial-derived metabolites, are required to traverse the intestinal barrier to enter the circulation. Consequently, the intestinal barrier assumes a significant role in various physiological processes, as well as in the preservation of homeostasis within the CNS (Rothhammer et al. 2016; Fung et al. 2017; Pellegrini et al. 2018; Brescia and Rescigno 2021). For instance, one of the most explored microbial-derived metabolites, SCFAs, which are saturated fatty acids with fewer than six carbon atoms (Wong et al., 2006), have been found to alleviate gut epithelium injury (Chen et al., 2018; Li et al., 2022b) and regulate tight junctions (Zheng et al., 2017), therefore strengthening intestinal immunological barriers to reduce gut permeability and stopping pathogenic factors from invasion (Maslowski et al., 2009; Chang et al., 2014; Corrêa-Oliveira et al., 2016; Rodrigues et al., 2016). In contrast, dysbiosis of the gut microbiota may lead to alterations in the gut barrier, resulting in a “leaky gut” (Fasano, 2020) and making for the translocation of pathogens into the portal and systemic circulation, which contributes to neuroinflammation in CNS disorders such as ASD (Theoharides et al., 2013; Fasano, 2020). Apart from regulating the intestinal barrier, the gut microbiota also plays a role in the translocation of immune cells from the gut to the brain. In some cases, the term “translocation” stands for the process during which the gut microbiota interacts with immune cells locally and “trains” them to relocate to the CNS in order to perform certain functions. One example is that the gut microbiota activates a group of IFNγ+ NK cells that will in turn migrate to the CNS and induce the production of a type of anti-inflammatory astrocytes. These astrocytes induce cellular apoptosis in T cells through Tumor necrosis factor-related apoptosis-inducing ligand-decoy receptor 5 (TRAIL-DR5) signals and inhibit neuroinflammation as a result (Sanmarco et al., 2021). In addition to IFNγ+ NK cells, meningeal IgA+ plasma cells that are missing or decreased in germ-free (GF) mice are also confirmed by B-cell receptor sequencing to be originated from the gut. This type of plasma cells can migrate from the gut to the CNS, especially the meninges. Once into the meninges, these IgA+ plasma cells will prevent pathogenic factors from entering by trapping them in the dural sinuses, thus guarding the developing brain against infection, which highlights the role of the gut microbiota in preventing infectious encephalitis caused by pathogenic bacteria through training B-cell immunity (Fitzpatrick et al., 2020). Interestingly, in

Read the complete text